Metronidazole lotion 0.75% is a prescription preparation for skin use in rosacea care. Its concentration is 7.5 mg per gram, like certain metronidazole creams and gels, but lotion is a distinct vehicle with its own labeling and handling characteristics. The older MetroLotion trade name and approved generic topical lotion records may appear in U.S. product information; neither a trade name nor an NDC constitutes a real-time stock report.
This page focuses on the 0.75% lotion itself: how to identify it, why the vehicle matters, what the labeled rosacea indication covers, where the brand reference fits and how to interpret generic records. It is separate from the lotion purchase workflow, which addresses pharmacist communication and pharmacy access.
Patients should not infer that 0.75% lotion can be replaced by 0.75% cream or gel without review, despite a shared active drug. A prescriber chooses the product based on the clinical situation and the dispensing pharmacist confirms what can lawfully be supplied. Use the topical metronidazole overview for the broader three-vehicle comparison.
A topical 0.75% lotion contains 7.5 mg metronidazole per gram of formulation. The FDA-labeling record also identifies a range of inactive ingredients used to produce the lotion vehicle. Ingredients matter because a cream, gel and lotion with the same active concentration are not chemically identical final products.
When comparing a prescription to an online listing, verify both the vehicle and the route. A skin lotion must not be mistaken for a vaginal gel, oral suspension or a cosmetic over-the-counter moisturizer.
| Labeled element | 0.75% lotion | Why it should be checked |
|---|---|---|
| Active ingredient | Metronidazole | Do not identify by vehicle alone |
| Concentration | 0.75% or 7.5 mg/g | Different from 1% products |
| Dosage form | Lotion | Separate from cream and gel |
| Route | Topical skin use | Not vaginal, oral or eye use |
| Package | Manufacturer-specific bottle or labeled container | May differ from old brand photos |
Topical metronidazole lotion labeling addresses inflammatory lesions of rosacea. Rosacea can present with papules, pustules, persistent redness or other changes, and not all symptoms respond to the same approach. Dermatologic assessment is important because similar-looking rashes can require different therapies.
The American Academy of Dermatology describes a broader management approach including appropriate medicines and supportive skin care. A product guide is useful for identification but is not a means of diagnosing rosacea or selecting a treatment independently.
MetroLotion is a branded name associated with metronidazole 0.75% topical lotion. U.S. generic lotion labels are also available and may be updated more recently than historical brand packaging. These records are helpful in establishing the medicine's identity and route; they do not reveal whether a specific bottle can be ordered now.
Read the dedicated MetroLotion brand page for brand-level context. A pharmacy can provide the actual manufacturer or labeler, expiration and quantity for the product to be dispensed.
The lotion vehicle determines part of how the product is formulated and applied, and inactive ingredients may influence tolerability. A patient may prefer the feel of lotion, but a clinician should decide whether it is suitable for the presentation and any sensitivities. Skin texture preferences do not prove equivalence with a gel or cream.
A proposed substitution should account for the prescribed dosage form and the label, not just the nominal 0.75% strength. See 0.75% cream and 0.75% skin gel for distinct vehicle explanations.
DailyMed and the dispensed leaflet describe the medicine's storage, precautions and labeled method of use. Patients should follow those instructions, avoid use on unintended sites and ask about irritation or unusual symptoms. A generic lotion formulation can have particular inactive ingredients, so relying on an old leaflet for a different manufacturer can be misleading.
Topical treatment does not eliminate the need to discuss allergies, pregnancy or breastfeeding concerns and other medicines with an appropriate professional. Such discussions are patient-specific and cannot be settled by a general product comparison.
DailyMed lists prescription lotion labeling and NDC information for particular labelers. The FDA Orange Book addresses approved drugs and therapeutic equivalence; these records are not inventory systems. A patient may see several brand and generic names online while a pharmacy has only one supplier available or no immediate stock.
If a pharmacist suggests another product, ask whether the proposed medicine is the same prescribed lotion or a different vehicle requiring prescriber clarification. Avoid interpreting an online search result as proof that a package remains marketed.
Confirm metronidazole, 0.75%, lotion, skin-use route and the exact directions on the pharmacy label. Check the container quantity and patient identification. A change in manufacturer can affect bottle appearance without altering the identity of the approved medicine, but a gel or cream arriving under a lotion prescription requires review.
A licensed pharmacist can resolve apparent differences between older MetroLotion brand materials and the actual generic dispensed. Keep the current product leaflet for future questions.
The reader's product-identification question is different from questions about shipping, pricing or licensed internet pharmacies. The lotion pharmacy guide handles legitimate purchase routes and what to ask when an order cannot be filled.
This page does not promise that an approved product is continuously stocked and does not recommend changing to cream or gel for convenience. Clinical and pharmacy decisions should be grounded in the written order and current label.
Metronidazole lotion 0.75% and topical gel 0.75% both refer to skin products for rosacea, but the dosage forms and inactive ingredients differ. A patient may prefer one vehicle on practical grounds; however, a clinician should decide whether a different formulation meets the treatment plan. The gel versus lotion guide explains those formulation features without presenting an automatic substitute.
The shared concentration cannot be used to derive an at-home conversion of the amount applied. The pharmacist should verify the prescribed vehicle and instructions. If a lotion order cannot be supplied, the next step is professional clarification—not substitution based on an online comparison table.
A lotion and a cream may both contain 7.5 mg/g metronidazole, but their excipients and formulation properties are distinct. A patient who reports sensitivity to a cream ingredient should not assume that any lotion has fewer irritating components without checking its actual label. The cream versus lotion comparison helps frame the questions about vehicle differences and label information.
When changing forms becomes a clinical consideration, note the exact manufacturer and prior product. This information can help a clinician distinguish a reaction to the active drug from a possible vehicle-related concern. Do not treat a formulation discussion as a self-care experiment.
Lotion claims can depend on the submitted dosage form, NDC, package quantity and whether the pharmacy is in the insurer's network. Coverage for a metronidazole gel does not by itself prove the same coverage or patient cost for a lotion. Use the topical insurance guide to prepare questions about preferred products, authorization and deductibles rather than assuming an evergreen cash price.
If the insurer appears to prefer a cream or gel, a pharmacist can explain what is covered and whether the prescriber needs to review a change. The pharmacy's ability to order a lotion and the insurer's willingness to reimburse it are separate practical questions.
Metronidazole lotion 0.75% should be identified by ingredient, concentration, lotion vehicle and skin route. Ask a pharmacist to verify all four if a listing is ambiguous, then confirm the container and directions actually supplied.
The precision is especially useful because dermatologic creams and gels may display the same percentage in pharmacy search results while being different dosage forms.
It is a prescription topical lotion containing metronidazole 7.5 mg/g, used for inflammatory lesions of rosacea.
Yes. MetroLotion is a brand associated with 0.75% topical metronidazole lotion.
No. Both may contain the same concentration but have different pharmaceutical vehicles.
Not without pharmacist or prescriber review of the exact prescription and product.
Yes. DailyMed contains approved generic prescription metronidazole 0.75% topical lotion labels.
No. It requires a valid U.S. prescription.
No. It is formulated and labeled for skin use, not intravaginal administration.
No stock claim follows from a brand label. Ask a dispensing pharmacy about current supply and product identity.
Discuss symptoms and the exact dispensed formulation with the clinician or pharmacist rather than altering treatment yourself.
Ingredient, 0.75% concentration, lotion vehicle, topical route, quantity and written directions.